Healthy Populations Exam 3 Practice

This question tests understanding of what the meningococcal B vaccine actually protects against. The MenB vaccines are designed to protect against disease caused by Neisseria meningitidis serogroup B specifically. They do not guard against meningococcal disease from other serogroups (such as A, C, W, or Y), and they are not an indication for preventing gonorrhea. The vaccination is commonly given to adolescents, typically around 16–18 years old, with some guidelines allowing catch-up through late teens or early adulthood. So, the best choice is that it provides protection specifically against serogroup B meningococcal disease in that age range.